TFAP2A and gastric cancer: The zinc-finger protein 471 was shown to inhibit gastric cancer progression through transcriptionally repressing downstream PLS3 and TFAP2A, suggesting that TFAP2A and PLS3 act as oncogenic factors in gastric cancer cell development (32).